OTC Watch

All stocks / FEED

ENvue Medical, Inc. FEED

ENvue Medical (FEED): shares outstanding up 1291% in a year, a late 10-Q notice in August 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated floatLate filing Pink LimitedTexas, USA
Live quote on OTC Markets

Market listing

Full name
ENVUE MED INC
Market tier
OTC Pink Limited
Trading status
Active
Last trade
Nov 16
Website
www.agfeedinc.com
Source: Stockwatch, 2026-11-17

News headlines

ENvue Medical Commences U.S. Production of UroShield(R) and Begins Fulfilling UK Distributor Orders
2026-10-29 07:30 · News Release
ENvue Medical Issues Letter to Shareholders
2026-10-26 07:30 · News Release
ENvue Medical Provides Nasdaq Listing Update
2026-09-15 12:45 · News Release
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield(TM) and Begins Fulfilling Open Distributor Orders
2026-09-09 08:30 · News Release
ENvue Medical Selected to Exhibit ENvue(TM) Navigation Platform at Vizient Innovative Technology Exchange
2026-09-02 08:30 · News Release
ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
2026-08-28 08:00 · News Release
ENvue Medical Announces Exclusive UroShield(TM) Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
2026-08-18 08:30 · News Release
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
2026-08-12 08:36 · News Release
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
2026-08-04 09:00 · News Release
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
2026-07-23 08:30 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$2,553,000
Net loss
($18,185,000)
What it means

It spends more than it earns

Under strain

Customers paid it $2.6 million in the year. It lost $18.2 million. For every $1 that came in, about $8.12 went out.

The report says
Cash and cash equivalents
$4,224,000
Net cash used in operating activities
($9,372,000)
What it means

The cash could run out soon

Under strain

It had $4.2 million in the bank and used about $781,000 a month. At that pace the money lasts about 5 months unless it borrows or sells more shares.

The report says
Total assets
$41,124,000
Total liabilities
$7,627,000
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $41.1 million. Its debts and unpaid bills add up to $7.6 million. That is about $0.19 owed for every $1 owned.

What this adds up to

2 of 3 checks show strain. It spends more than it earns. The cash could run out soon. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-08-17

Shares outstanding rose from 796,950 (2025-08-19) to 11,084,615 (2026-08-17), up 1291%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-08-17

Estimated float about 11,084,615 shares as of 2026-08-17: 11,084,615 outstanding minus 0 held by 1 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-08-14

Filed NT 10-Q on 2026-08-14: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-05-15

Filed NT 10-Q on 2026-05-15: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-03-31

Filed NT 10-K on 2026-03-31: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-09-30
1.0M
2025-11-14
1.1M
2025-12-31
1.1M
2026-03-31
3.7M
2026-04-15
3.7M
2026-05-18
6.1M
2026-06-30
8.2M
2026-08-17
11.1M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-10-14 8-K8-K
2026-09-03 EFFECT
2026-08-31 8-K8-K
2026-08-17 10-Q10-Q
2026-08-14 8-K8-K
2026-08-14 NT 10-QNT 10-Q
2026-08-12 8-K8-K
2026-08-10 S-3S-3
2026-07-24 DEF 14ADEF 14A
2026-07-14 8-K8-K
2026-07-14 PRE 14APRE 14A
2026-07-10 8-K8-K

Common questions about FEED

Does FEED file reports with the SEC?

Yes. ENvue Medical files with the SEC under company number 0001326706. The most recent filing we hold is a 8-K dated 2026-10-14.

Source record

How many FEED shares are outstanding?

11,084,615 shares as of 2026-08-17, as reported to the SEC. That is up 1291% from 796,950 on 2025-08-19.

Source record

Has FEED filed reports late?

Yes. In the last 12 months it filed 3 late-filing notices, most recently a NT 10-Q on 2026-08-14. A notice means a report was not ready on time; check whether the report followed.

Source record

Who runs ENvue Medical?

Officers named in its insider filings: Nicole M. Fernandez-McGovern (Interim CFO).

Source record

Is ENvue Medical making money?

Customers paid it $2.6 million in the year. It lost $18.2 million. For every $1 that came in, about $8.12 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record